Back to search

Biogenetics & Tech Limited

14174403

active
Private Limited Company
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

C/O M GEORGHIADES & ASSOCIATES, POTTERS BAR, EN6 1AF
Incorporated 15/06/2022

Compliance

Last accounts

30/06/2025

total exemption full

Next accounts due

31/03/2027

On track

Confirmation statement

Last: 14/06/2025

Due 28/06/2026

On track

Industry

72110
Research and experimental development on biotechnology
72200
Research and experimental development on social sciences and humanities

Officers

Mr Petros Theodotou

director · Since 15/06/2022

ACCOUNTANT/AUDITOR

CYPRIOT · CYPRUS · Age 63

Persons with Significant Control

Stamatios Molaris

75–100% shares
75–100% votes
Appoint directors

Greek · Cyprus · Age 64

C/O M Georghiades & Associates, 130a Darkes Lane, Potters Bar, EN6 1AF

Notified 15/06/2022

CompanyRankvs 2044+ SIC 72110 peers
36

Financial strength56th percentile among SIC peers · 14/25
Employees47th percentile among SIC peers · 7/15
LiquidityCurrent ratio 0.82× · 6/20
Longevity4 years trading (max 15) · 4/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Charles River U.K. Limited
90
2Werfen Limited
90
3Biopharma Process Systems Limited
90
4Theradex (Europe) Limited
90
5Spicer Consulting Limited
90
6Exmoor Pharma Concepts Limited
90
7Ubc Late Stage (Uk) Limited
90
8Wuxi Apptec Uk Ltd
90
9Cenobiologics Ltd
90
10Ccm Technologies Limited
90
2044Biogenetics & Tech Limited
42
How is this score calculated?
Financial strength14/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity4/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

this it's an ongoing conflict neither Biogenetics & Tech Limited nor the owners have any direct or indirect impact or sanctions from these on the company's ability to continue trading as a going concern. The company directors and owners will continue monitoring and reviewing the situation very close and report for any changes may arises if so. Page 7 continued... Biogenetics & Tech

Key FinancialsYear ending 30/06/2025

Net Worth

£1k

Balance sheet strength

Cash

£5k

Cash in the bank

Net Current Assets

-£128k

Working capital

Current Assets

£583k

Current Liabilities

£711k

Debtors

£578k

Profit After Tax

-£83k

1avg. employees

Balance Sheet

Assets less current liabilities-£128k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.82+£0
20250.82+£0
20240.93—

Derived from filed accounts. Not audited figures.